TB
Tia L Bush
Chief Technology & Quality Ofc

Tia L Bush insider trades: Centessa Pharmaceuticals (CNTA) stock buys and sales

Chief Technology & Quality Ofc, Centessa Pharmaceuticals Last trade Nov 17, 2025 26 Form 4 filings
$2.2M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2021
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Tia reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 17, 2025CNTA↓ Sell$1.1M
Nov 12, 2025CNTA↓ Sell$1.0M
Sep 24, 2025CNTA↓ Sell$840K
Sep 10, 2025CNTA↓ Sell$1.0M
Feb 3, 2025CNTA↓ Sell$185K
Dec 17, 2024CNTA↓ Sell$478K
May 24, 2023CNTA↓ Sell$36K
Oct 3, 2022CNTA↓ Sell$19K
Nov 16, 2021CNTA↑ Buy$62K
Jun 2, 2021CNTA↑ Buy$60K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CNTA insiders

Open-market trades in the last 12 months

About Tia L Bush's insider trades

Tia L Bush is Chief Technology & Quality Ofc at Centessa Pharmaceuticals (CNTA). Since Jun 2, 2021, Tia has reported 2 open-market purchases worth $122K and 8 sales worth $4.8M on SEC Form 4. In the last 12 months: 2 sales ($2.2M).

Their filings also include shares withheld for taxes (13 filings), grants and awards (7 filings), option exercises (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.